Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4)

Mark J. Mulligan; Kirsten E. Lyke; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; Kathleen Neuzil; Vanessa Raabe; Ruth Bailey; Kena A. Swanson; Ping Li; Kenneth Koury; Warren Kalina; David Cooper; Camila Fontes-Garfias; Pei Yong Shi; Özlem Türeci; Kristin R. Tompkins; Edward E. Walsh; Robert Frenck; Ann R. Falsey; Philip R. Dormitzer; William C. Gruber; Uğur Şahin; Kathrin U. Jansen

doi:10.1038/s41586-020-03098-3

Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4)

Mark J. Mulligan
, Kirsten E. Lyke
, Nicholas Kitchin
, Judith Absalon
, Alejandra Gurtman
, Stephen Lockhart
, Kathleen Neuzil
, Vanessa Raabe
, Ruth Bailey
, Kena A. Swanson
, Ping Li
, Kenneth Koury
, Warren Kalina
, David Cooper
, Camila Fontes-Garfias
, Pei Yong Shi
, Özlem Türeci
, Kristin R. Tompkins
, Edward E. Walsh
, Robert Frenck

Ann R. Falsey, Philip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen

Biochemistry & Molecular Biology

Research output: Contribution to journal › Comment/debate › peer-review

14 Scopus citations

Abstract

In the print version of this Article, some of the symbols were corrupted in Fig. 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.

Original language	English (US)
Pages (from-to)	E26
Journal	Nature
Volume	590
Issue number	7844
DOIs	https://doi.org/10.1038/s41586-020-03098-3
State	Published - Feb 4 2021

ASJC Scopus subject areas

General

Access to Document

10.1038/s41586-020-03098-3

Cite this

Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fontes-Garfias, C., Shi, P. Y., Türeci, Ö., Tompkins, K. R., Walsh, E. E., ... Jansen, K. U. (2021). Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4). Nature, 590(7844), E26. https://doi.org/10.1038/s41586-020-03098-3

Mulligan, MJ, Lyke, KE, Kitchin, N, Absalon, J, Gurtman, A, Lockhart, S, Neuzil, K, Raabe, V, Bailey, R, Swanson, KA, Li, P, Koury, K, Kalina, W, Cooper, D, Fontes-Garfias, C, Shi, PY, Türeci, Ö, Tompkins, KR, Walsh, EE, Frenck, R, Falsey, AR, Dormitzer, PR, Gruber, WC, Şahin, U & Jansen, KU 2021, 'Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4)', Nature, vol. 590, no. 7844, pp. E26. https://doi.org/10.1038/s41586-020-03098-3

@article{af7072fabef74287abeb3040bc3405ae,

title = "Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4)",

abstract = "In the print version of this Article, some of the symbols were corrupted in Fig. 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.",

author = "Mulligan, \{Mark J.\} and Lyke, \{Kirsten E.\} and Nicholas Kitchin and Judith Absalon and Alejandra Gurtman and Stephen Lockhart and Kathleen Neuzil and Vanessa Raabe and Ruth Bailey and Swanson, \{Kena A.\} and Ping Li and Kenneth Koury and Warren Kalina and David Cooper and Camila Fontes-Garfias and Shi, \{Pei Yong\} and {\"O}zlem T{\"u}reci and Tompkins, \{Kristin R.\} and Walsh, \{Edward E.\} and Robert Frenck and Falsey, \{Ann R.\} and Dormitzer, \{Philip R.\} and Gruber, \{William C.\} and Uğur {\c S}ahin and Jansen, \{Kathrin U.\}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = feb,

day = "4",

doi = "10.1038/s41586-020-03098-3",

language = "English (US)",

volume = "590",

pages = "E26",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Research",

number = "7844",

}

TY - JOUR

T1 - Publisher Correction

T2 - Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4)

AU - Mulligan, Mark J.

AU - Lyke, Kirsten E.

AU - Kitchin, Nicholas

AU - Absalon, Judith

AU - Gurtman, Alejandra

AU - Lockhart, Stephen

AU - Neuzil, Kathleen

AU - Raabe, Vanessa

AU - Bailey, Ruth

AU - Swanson, Kena A.

AU - Li, Ping

AU - Koury, Kenneth

AU - Kalina, Warren

AU - Cooper, David

AU - Fontes-Garfias, Camila

AU - Shi, Pei Yong

AU - Türeci, Özlem

AU - Tompkins, Kristin R.

AU - Walsh, Edward E.

AU - Frenck, Robert

AU - Falsey, Ann R.

AU - Dormitzer, Philip R.

AU - Gruber, William C.

AU - Şahin, Uğur

AU - Jansen, Kathrin U.

PY - 2021/2/4

Y1 - 2021/2/4

N2 - In the print version of this Article, some of the symbols were corrupted in Fig. 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.

AB - In the print version of this Article, some of the symbols were corrupted in Fig. 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.

UR - https://www.scopus.com/pages/publications/85100045235

UR - https://www.scopus.com/pages/publications/85100045235#tab=citedBy

U2 - 10.1038/s41586-020-03098-3

DO - 10.1038/s41586-020-03098-3

M3 - Comment/debate

C2 - 33469216

AN - SCOPUS:85100045235

SN - 0028-0836

VL - 590

SP - E26

JO - Nature

JF - Nature

IS - 7844

ER -

Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (Nature, (2020), 586, 7830, (589-593), 10.1038/s41586-020-2639-4)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this